Milestones from the forefront of Alzheimer's treatment.
Oxford Brain Diagnostics and Memory Treatment Centers (Bonita Springs and Jacksonville, Florida) establish a research collaboration to explore Alzheimer's disease in subjects who are cognitively impaired and receiving anti-amyloid treatment, as the global Alzheimer's community enters a new era of drug treatments for Alzheimer's patients.
In a groundbreaking move, Leqembi received traditional approval from the FDA for the treatment of Alzheimer's disease. Memory Treatment Centers continues to offer this therapy to eligible patients.
Memory Treatment Centers neurologist Jamie Plante and a current Leqembi patient were interviewed by the Wall Street Journal to investigate availability of new Alzheimer's treatments.
Memory Treatment Centers, a leading neurocognitive disease clinic, became among the first medical organizations in the United States to offer the innovative Alzheimer's drug Leqembi (lecanemab-irmb).
Memory Treatment Centers is pleased to announce that the Food and Drug Administration approved lecanemab, a new drug for the treatment of Alzheimer's disease.
Early detection and treatment lead to better outcomes. Time is precious. Time is brain.
Schedule a Visit Request a Call Back
